{"id":"W3129801150","doi":"10.1016/j.jval.2017.08.764","title":"Cost-Effectiveness Analysis of Secukinumab in Ankylosing Spondylitis: A Canadian Perspective","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Golimumab; Adalimumab; Secukinumab; BASDAI; Certolizumab pegol; BASFI; Infliximab; Population; Ankylosing spondylitis; Etanercept; Cost effectiveness; Adverse effect; Internal medicine; Disease; Tumor necrosis factor alpha; Environmental health","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006193318,0.0001273288,0.0007182974,0.0008661309,0.0001954819,0.00001570383,0.0000833761,0.00006196136,0.00005543423],"category_scores_gemma":[0.0003150966,0.0001262786,0.0001119196,0.0005577862,0.0000874941,0.00006789959,0.00002906805,0.0001535879,0.000002762397],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00239299,"about_ca_system_score_gemma":0.0007348653,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9459299,"about_ca_topic_score_gemma":0.7073393,"domain_scores_codex":[0.9986081,0.0001756194,0.0003140351,0.0003094262,0.0001662365,0.0004266495],"domain_scores_gemma":[0.9989867,0.0001171794,0.0001594421,0.0004269943,0.0000978092,0.0002118295],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002973117,0.0002124959,0.9872716,0.0001183515,0.0004353939,0.0004768509,0.003967037,0.0003937036,0.000006599173,0.00300823,0.000005624557,0.003806777],"study_design_scores_gemma":[0.003172854,0.000302371,0.9917046,0.0007422902,0.0001258594,0.00001305518,0.00194489,0.001268617,0.00002406943,0.0003540607,0.0002642401,0.00008310514],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925664,0.002476022,0.000005249292,0.001172386,0.0001103293,0.0009455561,0.0002926048,0.000007519448,0.002423907],"genre_scores_gemma":[0.9992551,0.0003389381,0.0001548408,0.0001031931,0.0000231495,0.00005995292,0.00003648664,0.00001233287,0.00001601766],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2385906,"threshold_uncertainty_score":0.6257585,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08393438153360656,"score_gpt":0.3907806412306049,"score_spread":0.3068462596969984,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}